Unilife Corp. has entered an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with an undisclosed, early-stage drug target. Unilife has also granted Novartis an option for exclusivity. Additional terms of the agreement were not disclosed.   Unilife will supply a customized delivery device, consisting of syringe, needle, tubing, controller and pump, for the administration of an investigational Novartis drug into a targeted o...